MULTIPLE MYELOMA NEVER GIVES UP. BUT NEITHER DO WE.
Celgene Corporation
Application Filed: 2013-04-26
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85915816 |
| Registration Number | 4432573 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Camille M. Miller |
| Attorney Docket Number | 335628/CELG- |
| Law Office Assigned | L40 |
| Employee Name | DUONG, ANGELA GAW |
Timeline
| 2012-07-01 | Date of First Use |
| 2013-04-26 | Application Filed |
| 2013-08-27 | Published for Opposition |
| 2013-11-12 | Trademark Registered |
| 2018-12-07 | Location: TMEG LAW OFFICE 104 |
| 2018-12-07 | Status: Live/Registered |
| 2018-12-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Celgene Corporation |
| Address | 86 Morris Avenue Summit DE 07901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 200308 | Blueprints; Charts; Diagrams; Graph paper; Paper, graph; Periodic chart of the elements and similar graphics |
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2013-04-30 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2013-05-03 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2013-05-04 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2013-07-16 | 4 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-07-19 | 5 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2013-08-07 | 6 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2013-08-27 | 7 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-08-27 | 8 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2013-11-12 | 9 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-07-28 | 10 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2018-11-12 | 11 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2018-11-12 | 12 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-12-07 | 13 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2018-12-07 | 14 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2018-12-07 | 15 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2022-11-12 | 16 REM2 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-12-09 | 17 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-12-09 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-12-09 | 19 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2022-12-09 | 20 EWAF I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-12-09 | 21 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-12-09 | 22 CHAN I:Incoming Correspondence |
| CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2024-05-28 | 23 CAEX O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MULTIPLE MYELOMA NEVER GIVES UP. BUT NEITHER DO WE. 85915816 4432573 Live/Registered |
Celgene Corporation 2013-04-26 |
 MULTIPLE MYELOMA NEVER GIVES UP. BUT NEITHER DO WE. 85915690 4432572 Live/Registered |
Celgene Corporation 2013-04-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 